peutic agents and many other substances used for selfpoisoning. Although the potential capacity for glucuronide conjugation is large, saturation may occur with some drugs at doses within or close to the therapeutic range. The phenolic glucuronidation of salicyclate may be cited as an example (Levyet al., 1972) , but this is only a minor pathway in man and of little toxicological significance.
The position is different with paracetamol. This drug is commonly taken in overdosage, and without specific therapy severe liver damage occurs in 8-10% of patients.
Glucuronide conjugation is the major route of metabolism, accounting for about 60% of a therapeutic dose and there is no decrease in this fraction after overdosage (Prescott, 1980) . The large capacity for glucuronide conjugation of paracetamol is a vital safety factor because its rapid removal by this pathway restricts the fraction which undergoes toxic metabolic activation by cytochrome P-450 dependent mixed function oxidase (Mitchell et al., 1974) . It has been claimed that liver damage following overdosage results from saturation and glucuronide conjugation with diversion to the toxic pathway, and a pharmacokinetic model has been proposed on this assumption . However, in poisoned patients who had not received specific therapy the plasma paracetamol half-life did not shorten progressively as concentrations fell to below the therapeutic range and there is thus no evidence of saturation kinetics (Prescott et al., 1971 ; Prescott, 1980) . Indeed, the reverse may occur.
In rare cases of exceptionally severe poisoning, such as the case shown in Fig. 1 , glucuronide conjugation probably does become saturated. This patient absorbed about 900mg/kg of paracetamol, and would almost certainly have died from hepatic failure without treatment. Fortunately, 
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Time from ingestion (h) intravenous N-acetylcysteine was given early and she suffered no hepatic or renal damage. The plasma paracetamol curve is consistent with saturation at concentrations above 450mg/l, but even so, other explanations are possible. Absorption could have been delayed, and initially liver blood flow was undoubtedly reduced because the patient was severely acidotic and hypotensive. In addition, the rate of disappearance of paracetamol from the plasma often increases several hours after treatment with N-acetylcysteine because sulphate conjugation is restored (see below). The elimination of paracetamol is delayed in patients who develop severe liver damage, but the half-life is prolonged from the outset and this seems to be due to immediate impairment of hepatic function with the first passage of the drug through the liver during absorption. Subsequently, conjugation may virtually cease in patients who suffer fatal liver damage (Prescott & Wright, 1973) .
The capacity for glucuronide conjugation of paracetamol after overdosage is thus very large unless the liver is badly damaged. It is not known whether conjugation in man is limited by the availability of UDPGA, but there is evidence that this may occur in mice (Galatulas & Montanari, 1976) . The glucuronide conjugation of paracetamol is enhanced in patients receiving chronic treatment with anticonvulsants or rifampicin (Prescott et al., 1981) , and the conjugation of bromosulphthalein is inhibited by paracetamol, presumably on the basis of competition or liver damage (Davis et al., 1975) .
Sulphate conjugation
Sulphate conjugation is an important route of metabolism for a number of compounds including ascorbic acid, steroids and phenols. It is of potential toxicological significance in that the capacity for sulphate conjugation is limited and saturation can be demonstrated at high therapeutic doses of some drugs. Formation of the cosubstrate for sulphate conjugation, PAPS, depends critically on the availability of inorganic sulphate, and conjugation may be restricted by its depletion (Mulder & Keulemans, 1978; Krijgsheld et al., 1982) . Sulphate is depleted by low protein diets and administration of substrates for conjugation but activity can be restored with sodium sulphate or compounds such as cysteine and N-acetylcysteine which are metabolised to inorganic sulphate (Schwartz, 1980; Krijgsheld et a/., 1981; Lin & Levy, 1981) . There may also be competition between substrates for sulphate conjugation (Levy & Yamada, 1971) .
Few examples are known of toxicity in man caused by limited sulphate conjugation. However, salicylamide inhibits the intestinal sulphate conjugation of isoprenaline and potentiates its pharmacological effects (Bennett et al., 1975) . Dose-dependent saturation of the sulphate conjugation of paracetamol occurs within the therapeutic range, and it is greatly impaired after overdosage, even in the absence of liver damage (Table 1) . The saturation of sulphate conjugation following large doses of paracetamol is due in part to depletion of inorganic sulphate (Lin & Levy, 1981 ; Morris & Levy, 1982) , and it has been suggested that administration of inorganic sulphate would maintain sulphate conjugation after overdosage and thus protect against toxicity by enhancing its elimination. Sodium sulphate increased the acute LD,, of paracetamol in mice from 425 to 575 mg/kg (Slattery & Levy, 1977) , and sodium sulphate and N-acetylcysteine increased the formation of paracetamol sulphate and enhanced the elimination of paracetamol in rats . Similarly, in man Nacetylcysteine increases the plasma concentrations and urinary excretion of paracetamol sulphate following overdosage (Prescott, 1980) . N-Acetylcysteine clearly stimulates the sulphate conjugation of paracetamol, but this effect is unlikely to be of significance in protecting against liver damage in man. Its primary action is to stimulate glutathione conjugation of the hepatotoxic metabolite (see below).
Glutathione conjugation
Pulmonary, hepatic and renal toxicity may be caused by metabolic activation and the formation of reactive intermediates which bind covalently to essential proteins and enzymes. In some cases, reduced glutathione plays a vital protective role by combining with and inactivating these toxic metabolites (Mitchell & Jollow, 1975; Boyd et al., 1982; Trush et al., 1982) . The reactions are usually catalysed by glutathione S-transferases and the resulting conjugates are excreted into the bile and eventually appear in the urine as mercapturic acid and cysteine conjugates (Chasseaud, 1976) . Glutathione and other sulphydryl compounds also protect against the toxicity of heavy metals by forming a stable complex with the SH group. This forms the basis for the use of thiols in the treatment of poisoning with gold, arsenic, lead, mercury and copper (Sharma et al., 1981; Mitchell et al., 1982) .
Glutathione-dependent hepatotoxicity has been established for a variety of agents including halogenated hydrocarbons, furans, paracetamol and cocaine. There is a direct relationship between depletion of hepatic glutathione, formation of glutathione conjugate, covalent binding of the compound to hepatic proteins and liver cell necrosis. Toxicity can be prevented or reduced by glutathione precursors and related sulphydryl compounds (Mitchelletal., 1974; Strubelt etal., 1974; Docks& Krishna, 1976; Thor et al., 1979; Thompson et al., 1979; Moldeus, 1981 ; Prescott, 1982) .
From a clinical toxicological point of view, paracetamol poisoning is the most important example of protection by glutathione against liver damage. As predicted by Mitchell et al. (1974) , there is a threshold dose level in man of 200-250mg/kg above which the incidence and severity of liver damage increases sharply (Prescott, 1983) . This presumably corresponds to the point of critical depletion of hepatic glutathione. Provided treatment is started within 8-10h of ingestion of the paracetamol, compounds such as cysteamine, N-acetylcysteine and methionine have proved remarkably effective in preventing liver damage, renal failure and death following overdosage with this commonly used drug (Table 2) (Prescott et al., 1974; Prescott et al., 1979; Vale et al., 1981) . Intravenous N-acetylcysteine is currently the treatment of choice.
The reactive metabolite of paracetamol is probably Nacetyl-p-benzoquinoneimine (Mitchell et al., 1974; Miner & Kissinger, 1979) . N-Acetylcysteine and other sulphydryl compounds which protect against its hepatotoxicity are thought to act primarily by providing cysteine to facilitate glutathione synthesis and the subsequent glutathione S-transferase catalysed conjugation of the reactive metabolite (Rollins & Buckpitt, 1979; Moldeus, 1981) . In keeping with this hypothesis, N-acetylcysteine increases the urinary excretion of the mercapturic acid and cysteine conjugates of paracetamol in poisoned patients (Prescott, 1980) . However, N-acetyl-cysteine may also protect against liver damage by reducing the N-acetyl-p-benzoquinoneimine back to paracetamol (Lauterburg et al., 1982) .
The treatment of paracetamol poisoning has been revolutionized by the introduction of N-acetylcysteine and other sulphydryl antidotes, and there is no doubt that the toxicity of many other compounds could be prevented similarly (Prescott, 1982) . For example, chloroform produces hepatic and renal damage and is potentially carcinogenic. It is converted to the highly toxic carbonyl chloride (phosgene) which is inactivated by conjugation with glutathione and excreted as the cysteine derivative, 2-oxothiazolidine-4-carboxylic acid (Pohl et al., 1980) . As with paracetamol and bromobenzene, chloroform-induced liver damage is associated with covalent binding and glutathione depletion and can be prevented by treatment with cysteine (Docks & Krishna, 1976) .
Glycine conjugation of salicylate
Salicylate intoxication is a common medical emergency which carries a significant mortality, especially in young children. At low therapeutic doses, the major route of salicylate metabolism is conjugation with glycine to form salicylurate. This conjugate has a renal clearance of about 500ml/min in adults and is thus rapidly excreted. However, salicylurate formation is saturated well within the therapeutic dose range. In adults, the K,,, value is about 5mg/kg and the maximum rate of salicylurate formation is about 0.9mg/h per kg (Levy, 1978) .
Saturation of the glycine conjugation of salicylate has important toxicological implications. Most of a low thera- peutic dose of salicylate is converted to salicylurate and rapidly eliminated with a half-life in adults of 3-4h. At high therapeutic doses and following overdosage, salicylurate formation is completely saturated and the half-life is prolonged to about 30h. Thus not only is recovery from overdosage very slow, but there is a serious danger of cumulation and toxicity with repeated high therapeutic doses. Such 'therapeutic' overdosage is often unrecognized and carries a high mortality, especially in young children (Anderson et al., 1976; Done, 1978) . The other routes of salicylate metabolism are of little quantitative significance, and the only remaining mechanism for its elimination is renal excretion. Fortunately, the renal clearance of salicylate is highly pH-dependent, and urinary alkalinization is employed routinely to enhance its removal following overdosage. As shown in Table 3 , alkalinization of the urine has a striking effect on the urinary excretion of salicylate and the salicylurate to salicylate ratio, but only a modest effect on the plasma salicylate half-life in healthy volunteers given a single oral dose of 20mg/kg of aspirin. This is because most of the dose is converted to salicylurate under all conditions, despite partial saturation. Following overdosage, urinary alkalinization has a proportionately much greater effect on the elimination of salicylate. Salicylurate formation is now fully saturated and if renal function is not impaired, plasma concentrations remain low (< IOpg/ml) and constant, irrespective of urine pH or flow rate. The maximum rate of removal by this route in adults is only 50-60mg/h . Alkalinization of the urine dramatically increases the renal clearance of salicylate, and this becomes the dominant route of elimination with a corresponding marked increase in the rate of elimination of salicylate from the body. Indeed, the ratio of the percentages recovered as salicylurate and salicylate is completely reversed by making the urine alkaline (Table 3) .
But for the pH-dependent renal clearance of salicylate, intoxication would be prolonged and the risk of serious complications and a fatal outcome would be considerably increased. In a recent study of patients with aspirin poisoning, the administration of glycine reduced the time taken to recover 50% of the total overdosage of salicylate, suggesting that salicylurate formation might be limited by the availability of glycine. However, the fraction recovered as salicylurate was not increased (Notarianni et al., 1983) . The glycine conjugation of salicylate is inducible, and this may be relevant during long-term high dose therapy (Day et al., 1983) .
Summary
Conjugation is an important mechanism for the rapid inactivation and extensive removal of drugs and poisons from the body, and as such it is of major significance in clinical toxicology. The capacity for conjugation of some drugs is large, but with others, saturation may occur with overdosage or even high therapeutic doses. Glutathione conjugation is an important mechanism of protection against toxicity produced by heavy metals, alkylating agents and some compounds which undergo metabolic activation.
Introduction
The Ah locus controls the induction, by polycyclic aromatic compounds such as TCDD and MC, of a few of the total number of forms of P-450. Cytochrome P-450 is defined as all forms of CO-binding membrane-bound haemoproteins having NADPH-and sometimes NADHAbbreviations used : AHH, aryl hydrocarbon (benzo[a]pyrene) hydroxylase (EC 1.14.14.1); B6, the C57 BL/6N inbred mouse strain; bp, base pair; DC, the DBA/2N inbred mouse strain; kbp, kilobase pair; MC, 3-methylcholanthrene; TCDD, 2,3,7,8-tetrachlorodi benzo-p-dioxin. dependent mono-oxygenase activities. 'P,-450' is defined as that form of polycyclic aromatic-inducible P-450 most closely associated with polycyciic aromatic-inducible aryl hydrocarbon hydroxylase activity. 'P2-450' is defined as that form of isosafrole-induced enzyme which metabolizes isosafrole best. 'P3-450' is defined as that form of polycyclic aromatic-induced enzyme most clearly associated with polycyclic aromatic-inducible acetanilide 4-hydroxylase activity. 'P3-450' is the major MC-inducible form in the mouse and is 4 to 7 times greater in amount than either PI-450 or P2-450. Since P2-450 and P,-450 both exhibit Soret peaks at 448nm when reduced and combined with CO, we have chosen to rename 'mouse P-448' (Negishi & Nebert, 1979) P3-450. P,-450 is one of these forms. The incubation process is mediated by the cytosolic Ah receptor (reviewed in Eisen et al., 1983). Numerous relatively planar foreign chemicals bind avidly (apparent Kd approx. I nM) to the Ah receptor in direct proportion to their potency as inducers of
